Algenix

Abgenix is a biopharmaceutical company dedicated to the discovery, development, and manufacture of human therapeutic antibodies for the treatment of various diseases such as cancer, inflammation, and metabolic disorders. Antibody therapeutic product candidates in its clinical trials include Panitumumab (ABX-EGF), a human antibody therapeutic product candidate targeting the epidermal growth factor receptor, and a candidate for the treatment of various solid tumors. It also includes ABX-10241 (ABX-PTH), a fully human antibody therapeutic product candidate targeting parathyroid hormone for the treatment of secondary hyperparathyroidism.